| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 51.56B | 50.03B | 50.30B | 46.19B | 43.45B | 39.28B |
| Gross Profit | 10.57B | 10.88B | 10.31B | 9.84B | 9.19B | 8.15B |
| EBITDA | 5.83B | 6.61B | 6.33B | 5.83B | 5.48B | 4.69B |
| Net Income | 3.05B | 3.66B | 4.29B | 4.09B | 3.47B | 2.77B |
Balance Sheet | ||||||
| Total Assets | 46.71B | 47.18B | 44.18B | 40.74B | 36.85B | 32.69B |
| Cash, Cash Equivalents and Short-Term Investments | 18.24B | 19.67B | 18.81B | 15.35B | 15.18B | 12.38B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 10.15B | 11.77B | 11.00B | 10.86B | 10.33B | 9.07B |
| Stockholders Equity | 36.56B | 35.41B | 33.17B | 29.88B | 26.52B | 23.62B |
Cash Flow | ||||||
| Free Cash Flow | 2.85B | 3.46B | 4.76B | 1.55B | 3.49B | 1.63B |
| Operating Cash Flow | 3.28B | 3.85B | 5.05B | 2.00B | 3.73B | 2.00B |
| Investing Cash Flow | -1.78B | 6.41B | -8.70B | -1.01B | -344.00M | -583.00M |
| Financing Cash Flow | -1.28B | -1.41B | -894.00M | -818.00M | -607.00M | -520.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥33.87B | 11.66 | ― | 2.97% | 16.59% | 40.56% | |
74 Outperform | ¥29.00B | 16.05 | ― | 2.45% | 19.04% | 30.67% | |
74 Outperform | ¥31.35B | 35.99 | ― | ― | 29.61% | 93.16% | |
72 Outperform | ¥37.99B | 12.27 | ― | 3.38% | -0.10% | -19.50% | |
65 Neutral | ¥31.81B | 6.28 | 10.34% | 4.82% | -3.03% | 38.83% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
55 Neutral | ¥33.11B | 29.01 | ― | ― | -10.49% | ― |